1528 / 1851
PORTEC-2 results
VBT EBRT
p
value
Vaginal recurrence 1.8% 1.6% 0.74
Pelvic recurrence
5.1% 2.1% 0.17
Acute GI toxicity
12.6% 53.8%
VBT is adjuvant treatment of choice for patients with
“high-intermediate risk” endometrial Ca